News
In a July 9 memo, the director of the FDA's Center for Biologics Evaluation and Research contended there was not enough ...
The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.
StockStory.org on MSN10h
Reflecting On Therapeutics Stocks’ Q1 Earnings: Moderna (NASDAQ:MRNA)As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...
Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. | In this tracker, Fierce Pharma is recording the ...
The Greater Boston Applied Field Lab is an academic experiential program at HKS affiliated with the Rappaport Institute and ...
23h
New York Magazine on MSNCan Doctors Predict Who Will Drop Dead?It’s as if sudden cardiac arrest is met with a resigned shrug: If it’s nearly impossible to predict and even harder to treat, ...
Spikevax has been fully approved for children ages 6 months through 11 years with high-risk conditions. HealthDay News — Moderna’s COVID-19 vaccine has received full approval from the U.S. Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results